January 04, 2017
Moderna Joins the Human Vaccines Project to Help Advance Fundamental Understanding of the Immune System
January 03, 2017
Moderna to Highlight its mRNA Development Candidate Pipeline at 2017 J.P. Morgan Healthcare Conference
October 27, 2016
Moderna Therapeutics Named the No. 3 Top Employer by Science Magazine
October 06, 2016
Moderna Appoints Annie Seibold Drapeau as Chief Human Resources Officer
September 21, 2016
Moderna to Build State-of-the-Art Fully Integrated GMP mRNA Clinical Manufacturing Facility in Norwood, Mass.
September 13, 2016
Moderna Appoints Melissa J. Moore, Ph.D., as Chief Scientific Officer of Moderna’s mRNA Research Platform
September 07, 2016
Moderna Enters New Growth Phase with Closing of $474 Million Equity Financing and its First BARDA Grant for up to $125 Million for Zika mRNA Vaccine
September 07, 2016
Moderna Announces Funding Award from BARDA for $8 Million with Potential of up to $125 Million to Accelerate Development of Zika Messenger RNA (mRNA) Vaccine
July 26, 2016
Moderna Therapeutics Provides Mid-Year Corporate Update, Announces Continued Clinical Development Progress and Pipeline Acceleration
July 26, 2016
AstraZeneca and Moderna Announce Filing of First Clinical Trial Application in Messenger RNA Therapeutics™ Collaboration